Adtech developer Fringe81, whose backers include corporates NTT Docomo, Dentsu and Itochu, is set to float on the Tokyo Stock Exchange.

Online identity verification platform Are You A Human has been acquired by Distil Networks, allowing corporate venturing unit MDC Dream Ventures to exit.

Bioverativ could end up paying $825m for rare disease drug developer True North, which had raised $142m from backers including GlaxoSmithKline, Biogen Idec, Baxter and Baxalta.

SoftBank, already a 33% shareholder, has reportedly acquired the stakes of three other Snapdeal board members, and Flipkart has signed a term sheet to buy it for a price that could be under $1bn.

Tencent, JG Summit and Uni-President Enterprises are set to record exits as Sea, the internet services firm formerly known as Garena, files confidentially to float in the US.

Wells Fargo has exited alternative investments analysis platform AltX in an acquisition by financial software producer Addepar.

The enterprise software company has invested an undisclosed sum in automated HR app creator BuildOnMe and acquired another artificial intelligence tool developer, Qlue.

VMware has acquired one of its portfolio companies, app performance management platform Apteligent, in a deal that also gave exits to Alphabet, AOL and Accenture.

Cancer therapy developer G1 Therapeutics has gone public in an initial public offering that gave an exit to long-time investor MedImmune Ventures.

The reverse merger with Nasdaq-listed Mirna, which counts Pfizer and Baxter as backers, was agreed alongside the disclosure of a $42m series C round.